Form 4: Perspective Therapeutics Director Acquires Shares in Open Market
SEC Form 4 Filing
Robert F. Williamson III, a director at Perspective Therapeutics, Inc., purchased 6,266 shares of common stock in the open market on November 25, 2024.
Summary
- Robert F. Williamson III, a director of Perspective Therapeutics, Inc., acquired 6,266 shares of common stock on November 25, 2024.
- The purchases were made in two transactions, with 3,647 shares bought at $3.6199 per share and 2,619 shares at $3.67 per share.
- Following these transactions, Williamson directly owns 430,058 shares and indirectly owns 3,663 shares through the RFW3 Revocable Trust.
- The transactions were reported on a Form 4 filing with the SEC.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as a director purchasing shares is generally seen as a good sign, indicating confidence in the company. However, it's a routine filing and not a major event.
Positives
- The director's purchase of shares indicates confidence in the company's future prospects.
- The open market purchase suggests a genuine belief in the company's value.
Industry Context
This is a routine filing related to insider trading activity, which is common for publicly traded companies. It provides transparency into the trading activities of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
- The reporting of insider transactions is a common practice across all publicly listed companies, including those in the biotechnology sector like Perspective Therapeutics.
- The level of detail provided in this filing is consistent with other Form 4 filings from similar companies.
Stakeholder Impact
- The share purchase may have a slightly positive impact on shareholder sentiment.
- The transaction does not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/25/2024 | Date of the share purchase transactions and the date of the power of attorney. |
| 11/27/2024 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
insider trading, Form 4, share purchase, director, Perspective Therapeutics, CATX, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.